What is the impact of personalized plantar temperature monitoring for DFU risk reduction?

Orpyx is leading the way in diabetic foot health management through personalizing plantar temperature monitoring to the individual.

Plantar temperature monitoring to identify early signs of foot inflammation has been included in several international guidelines on diabetic foot health management and prevention (IWGDF, PAVE). Current remote temperature monitoring protocols use a standard 2.2°C plantar temperature asymmetry threshold to identify early signs of foot inflammation.    

However, this fixed threshold may not be appropriate for every patient, especially those with comorbidities that present with baseline plantar temperature asymmetries. To better support individuals with comorbidities, the Orpyx Sensory Insole system now includes a personal baseline temperature asymmetry algorithm that helps minimize burdensome false positive temperature concerns and de-risk false negative temperature concerns. 

Discover insights on personalized monitoring in our white paper Personalized plantar temperature monitoring for DFU risk reduction:

• How personalized temperature monitoring is evolving and accounting for critical factors, such as patient comorbidities and clinical conditions that influence plantar temperature trends

• Patterns in plantar temperature trends that can signal shifts in a patient’s health status

• The clinical benefits of personalized plantar temperature monitoring, including fewer false positive temperature warnings

With the personalized temperature asymmetry algorithm, individuals who are burdened with comorbidities are no longer excluded from plantar temperature monitoring protocols but are instead supported by algorithms that are personalized to them.

Download our comprehensive white paper here to read more.